Clinical Trials Browser

Interventional × Graft vs Host Disease × Infliximab × Clear all

NCT00228839 2009-06-30

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Phase 1 Completed

Graft vs Host Disease